Skip to main content
. 2006 Aug 29;95(6):677–682. doi: 10.1038/sj.bjc.6603321

Table 2. Dose escalation and DLTs.

Dose (mg m−2) Number of patients DLTs (n)
300 3 None
500 3 None
600 3 None
700 6 G3 ALT elevation (1)
800 3 None
900 4a None
1000 3 None
1200 6 G3 infection (1); G3 rash (1)

ALT=alanine transaminase; DLT=dose-limiting toxicity; G3=grade 3.

a

One patient was excluded for DLT analysis because of grade 3 hyperglycemia at the beginning of the study.